A major discovery in cancer study is arising with the use of nanobodies to re-engage damaged p53. This vital cancer inhibitor protein is frequently disabled in several kinds of tumors, resulting uncontrolled tissue https://freshbookmarking.com/story21947477/mini-antibodies-revive-tumor-suppressor-p53-the-new-pathway-for-cancer-management